Sign up to save your podcasts
Or
Share Inhalable, Room-Temp, Needle-Free: Immuno‑Nanomed's Vaccine Moonshot
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Inhalable, Room-Temp, Needle-Free: Immuno‑Nanomed's Vaccine Moonshot
On this episode of the Iowa Tech Podcast, host Kaylee sits down with Dr. Balaji Narasimhan, CEO and founder of ImmunoNanoMed, to explore a moonshot innovation: a dry-powder, needle-free vaccine platform called "powder wax" that's inhaled through the nose. Balaji explains how their particle-based technology could deliver stronger, faster mucosal immunity right where respiratory pathogens take hold, improve protection against variants, and eliminate the cold chain—potentially slashing costs and enabling at-home, self-administered vaccination. He also shares how the platform could multiplex vaccines (think flu, RSV, COVID, pneumonia) and extend to companion animals and even livestock and poultry via mass-vaccination approaches, with an eye toward DIVA compatibility and safeguarding human health supply chains.
💡 Find this show on your favorite player: https://iowapodcast.com/immunonanomed...
🗞️ Be first to get new interviews: https://iowapodcast.com/subscribe/
🐖 Get a free $30 gift card from Jethro's BBQ: https://iowapodcast.com/jethrosbbq
Balaji traces the technology's origins to a Seahawk collaboration between Iowa State University and the University of Iowa, then details ImmunoNanoMed's path from lab success to commercialization: building a cross-functional team, partnering with CROs to get FDA-ready, pursuing scalable, high-quality manufacturing, and engaging potential big-pharma partners—all targeted over the next 6–18 months. He reflects on Iowa's innovation ecosystem (Startup Factory, I-Corps, IEDA, InnoVenture) and why he's committed to proving world-class health tech can emerge from the Midwest. The episode closes with personal notes on mentors, teamwork, and family, plus a call for collaborators. Learn more or get in touch at immunonanomed.com.
Chapters:
00:00 Introduction and Guest Welcome
01:01 Immuno Ed's Innovative Vaccine Technology
02:14 Advantages of Powder Wax Technology
04:18 Potential Applications and Impact
07:25 Journey and Collaborations
15:39 Challenges and Future Steps
18:30 Why Iowa?
22:04 Personal Inspirations and Family
25:04 Conclusion and Contact Information
View all episodes
By Iowa Tech PodcastOn this episode of the Iowa Tech Podcast, host Kaylee sits down with Dr. Balaji Narasimhan, CEO and founder of ImmunoNanoMed, to explore a moonshot innovation: a dry-powder, needle-free vaccine platform called "powder wax" that's inhaled through the nose. Balaji explains how their particle-based technology could deliver stronger, faster mucosal immunity right where respiratory pathogens take hold, improve protection against variants, and eliminate the cold chain—potentially slashing costs and enabling at-home, self-administered vaccination. He also shares how the platform could multiplex vaccines (think flu, RSV, COVID, pneumonia) and extend to companion animals and even livestock and poultry via mass-vaccination approaches, with an eye toward DIVA compatibility and safeguarding human health supply chains.
💡 Find this show on your favorite player: https://iowapodcast.com/immunonanomed...
🗞️ Be first to get new interviews: https://iowapodcast.com/subscribe/
🐖 Get a free $30 gift card from Jethro's BBQ: https://iowapodcast.com/jethrosbbq
Balaji traces the technology's origins to a Seahawk collaboration between Iowa State University and the University of Iowa, then details ImmunoNanoMed's path from lab success to commercialization: building a cross-functional team, partnering with CROs to get FDA-ready, pursuing scalable, high-quality manufacturing, and engaging potential big-pharma partners—all targeted over the next 6–18 months. He reflects on Iowa's innovation ecosystem (Startup Factory, I-Corps, IEDA, InnoVenture) and why he's committed to proving world-class health tech can emerge from the Midwest. The episode closes with personal notes on mentors, teamwork, and family, plus a call for collaborators. Learn more or get in touch at immunonanomed.com.
Chapters:
00:00 Introduction and Guest Welcome
01:01 Immuno Ed's Innovative Vaccine Technology
02:14 Advantages of Powder Wax Technology
04:18 Potential Applications and Impact
07:25 Journey and Collaborations
15:39 Challenges and Future Steps
18:30 Why Iowa?
22:04 Personal Inspirations and Family
25:04 Conclusion and Contact Information